Literature DB >> 4585965

A cooperative controlled study of the use of trimethoprim-sulfamethoxazole in chronic urinary tract infections.

R A Gleckman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4585965     DOI: 10.1093/infdis/128.supplement_3.s647

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Comparison of sulfamethoxazole alone and combined with trimethoprim in urinary tract infections.

Authors:  T Bergan; O Skjerven
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.

Authors:  G K Harding; A R Ronald; P Boutros; B Lank
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

3.  Comparative double-blind study of cephalexin and co-trimoxazole in urinary tract infections.

Authors:  P E Gower; P R Tasker
Journal:  Br Med J       Date:  1976-03-20

Review 4.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

5.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 7.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.